BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 24576449)

  • 1. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke.
    Golpe R; Sanjuán López P; Cano Jiménez E; Castro Añón O; Pérez de Llano LA
    Arch Bronconeumol; 2014 Aug; 50(8):318-24. PubMed ID: 24576449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Chronic Obstructive Pulmonary Disease Caused by Wood Smoke a Different Phenotype or a Different Entity?
    Torres-Duque CA; García-Rodriguez MC; González-García M
    Arch Bronconeumol; 2016 Aug; 52(8):425-31. PubMed ID: 27207325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women.
    Camp PG; Ramirez-Venegas A; Sansores RH; Alva LF; McDougall JE; Sin DD; Paré PD; Müller NL; Silva CI; Rojas CE; Coxson HO
    Eur Respir J; 2014 Mar; 43(3):725-34. PubMed ID: 24114962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure.
    Jindal SK; Aggarwal AN; Chaudhry K; Chhabra SK; D'Souza GA; Gupta D; Katiyar SK; Kumar R; Shah B; Vijayan VK;
    Indian J Chest Dis Allied Sci; 2006; 48(1):23-9. PubMed ID: 16482948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD).
    Izquierdo-Alonso JL; Rodriguez-Gonzálezmoro JM; de Lucas-Ramos P; Unzueta I; Ribera X; Antón E; Martín A
    Respir Med; 2013 May; 107(5):724-31. PubMed ID: 23419828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Major Comorbidities in Chronic Obstructive Pulmonary Disease Caused by Biomass Smoke or Tobacco.
    Golpe R; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añon O; Mengual-Macenlle N; Pérez-de-Llano L
    Respiration; 2017; 94(1):38-44. PubMed ID: 28456807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic obstructive pulmonary disease in women exposed to wood stove smoke.
    Moreira MA; Barbosa MA; Jardim JR; Queiroz MC; Inácio LU
    Rev Assoc Med Bras (1992); 2013; 59(6):607-13. PubMed ID: 24211014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke.
    Cho J; Lee CH; Hwang SS; Kim KU; Lee SH; Park HY; Park SJ; Min KH; Oh YM; Yoo KH; Jung KS;
    BMC Pulm Med; 2019 Mar; 19(1):68. PubMed ID: 30902075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational and Biomass Exposure in Chronic Obstructive Pulmonary Disease: Results of a Cross-Sectional Analysis of the On-Sint Study.
    López-Campos JL; Fernández-Villar A; Calero-Acuña C; Represas-Represas C; López-Ramírez C; Fernández VL; Casamor R;
    Arch Bronconeumol; 2017 Jan; 53(1):7-12. PubMed ID: 27432162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure.
    Ramírez-Venegas A; Sansores RH; Quintana-Carrillo RH; Velázquez-Uncal M; Hernandez-Zenteno RJ; Sánchez-Romero C; Velazquez-Montero A; Flores-Trujillo F
    Am J Respir Crit Care Med; 2014 Nov; 190(9):996-1002. PubMed ID: 25172140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking.
    Montaño M; Cisneros J; Ramírez-Venegas A; Pedraza-Chaverri J; Mercado D; Ramos C; Sansores RH
    Inhal Toxicol; 2010 Aug; 22(10):868-74. PubMed ID: 20583895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in chronic obstructive pulmonary disease phenotypes between non-smokers and smokers.
    Ji W; Lim MN; Bak SH; Hong SH; Han SS; Lee SJ; Kim WJ; Hong Y
    Clin Respir J; 2018 Feb; 12(2):666-673. PubMed ID: 27805311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Indices and Mortality Prediction in COPD Caused by Biomass Smoke Exposure.
    Golpe R; Mengual-Macenlle N; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez-de-Llano LA
    Lung; 2015 Aug; 193(4):497-503. PubMed ID: 25926292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study.
    Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F
    Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of chronic obstructive pulmonary disease and associated risk factors in Uganda (FRESH AIR Uganda): a prospective cross-sectional observational study.
    van Gemert F; Kirenga B; Chavannes N; Kamya M; Luzige S; Musinguzi P; Turyagaruka J; Jones R; Tsiligianni I; Williams S; de Jong C; van der Molen T
    Lancet Glob Health; 2015 Jan; 3(1):e44-51. PubMed ID: 25539969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco.
    Golpe R; Sanjuán-López P; Martín-Robles I; González-Juanatey C; Pérez-de-Llano L; López-Campos JL
    Lung; 2018 Apr; 196(2):195-200. PubMed ID: 29435736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemiological profile of chronic obstructive pulmonary disease: A community-based study in Delhi.
    Sinha B; ; Singla R; Chowdhury R
    J Postgrad Med; 2017; 63(1):29-35. PubMed ID: 27853040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of respiratory symptoms and lung function alterations in patients with chronic obstructive pulmonary disease related to the exposure to wood and tobacco smoke.
    Moreira MA; Moraes MR; Silva DG; Pinheiro TF; Vasconcelos Júnior HM; Maia LF; Couto DV
    J Bras Pneumol; 2008 Sep; 34(9):667-74. PubMed ID: 18982203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD.
    Meneghini AC; Koenigkam-Santos M; Pereira MC; Tonidandel PR; Terra-Filho J; Cunha FQ; Menezes MB; Vianna EO
    Braz J Med Biol Res; 2019; 52(5):e8233. PubMed ID: 31038579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
    Calle Rubio M; Casamor R; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.